Neuroone Total Liab vs Net Invested Capital Analysis

NMTC Stock

USD 0.61 0.07 10.29%

Neuroone Medical financial indicator trend analysis is infinitely more than just investigating Neuroone Medical Tec recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neuroone Medical Tec is a good investment. Please check the relationship between Neuroone Medical Total Liab and its Net Invested Capital accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Total Liab vs Net Invested Capital

Total Liab vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neuroone Medical Tec Total Liab account and Net Invested Capital. At this time, the significance of the direction appears to have weak relationship.

The correlation between Neuroone Medical's Total Liab and Net Invested Capital is 0.39. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Neuroone Medical Technologies, assuming nothing else is changed. The correlation between historical values of Neuroone Medical's Total Liab and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Neuroone Medical Technologies are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Total Liab i.e., Neuroone Medical's Total Liab and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.39

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most indicators from Neuroone Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neuroone Medical Tec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

At present, Neuroone Medical's Sales General And Administrative To Revenue is projected to increase significantly based on the last few years of reporting.

Neuroone Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Total Liab	Total Current Assets	Common Stock	Other Stockholder Equity	Short Term Debt	Current Deferred Revenue	Accounts Payable	Other Liab	Net Tangible Assets	Intangible Assets	Net Invested Capital	Net Working Capital	Capital Stock	Property Plant And Equipment Net
Common Stock Shares Outstanding		0.91	-0.15	0.64	0.39	0.89	-0.82	-0.94	0.88	0.84	0.88	-0.24	0.29	0.91	0.88	0.98	-0.22	-0.06	0.59	0.41	0.95	-0.44	0.92	0.91	0.72	0.91
Total Assets	0.91		-0.09	0.57	0.51	0.95	-0.95	-0.95	0.99	0.98	0.92	-0.21	0.41	1.0	0.8	0.94	-0.18	0.15	0.67	0.51	0.91	-0.32	0.99	0.99	0.76	0.92
Short Long Term Debt Total	-0.15	-0.09		0.61	0.75	-0.4	0.26	-0.01	-0.08	-0.09	0.12	0.92	0.81	-0.11	0.15	-0.06	0.99	0.55	0.35	0.42	-0.3	0.72	-0.07	-0.06	0.01	-0.08
Other Current Liab	0.64	0.57	0.61		0.82	0.32	-0.35	-0.67	0.54	0.49	0.67	0.51	0.82	0.55	0.69	0.66	0.57	0.39	0.57	0.66	0.45	0.23	0.57	0.58	0.49	0.59
Total Current Liabilities	0.39	0.51	0.75	0.82		0.21	-0.34	-0.53	0.49	0.52	0.57	0.64	0.99	0.51	0.51	0.45	0.72	0.71	0.67	0.66	0.26	0.38	0.5	0.51	0.34	0.47
Total Stockholder Equity	0.89	0.95	-0.4	0.32	0.21		-0.97	-0.88	0.94	0.93	0.83	-0.48	0.09	0.95	0.71	0.9	-0.48	-0.1	0.54	0.33	0.94	-0.53	0.94	0.94	0.74	0.88
Net Debt	-0.82	-0.95	0.26	-0.35	-0.34	-0.97		0.89	-0.97	-0.96	-0.85	0.34	-0.22	-0.95	-0.68	-0.86	0.35	-0.02	-0.63	-0.42	-0.88	0.4	-0.96	-0.96	-0.8	-0.87
Retained Earnings	-0.94	-0.95	-0.01	-0.67	-0.53	-0.88	0.89		-0.94	-0.89	-0.96	0.11	-0.43	-0.94	-0.91	-0.98	0.09	0.0	-0.75	-0.54	-0.92	0.31	-0.96	-0.97	-0.83	-0.96
Cash	0.88	0.99	-0.08	0.54	0.49	0.94	-0.97	-0.94		0.98	0.93	-0.21	0.39	0.99	0.79	0.93	-0.17	0.1	0.66	0.51	0.9	-0.3	0.99	0.99	0.84	0.92
Cash And Short Term Investments	0.84	0.98	-0.09	0.49	0.52	0.93	-0.96	-0.89	0.98		0.88	-0.2	0.42	0.99	0.72	0.88	-0.18	0.23	0.66	0.48	0.86	-0.29	0.97	0.97	0.74	0.87
Common Stock Total Equity	0.88	0.92	0.12	0.67	0.57	0.83	-0.85	-0.96	0.93	0.88		-0.03	0.47	0.91	0.93	0.96	0.01	-0.01	0.79	0.57	0.86	-0.2	0.95	0.95	0.87	0.93
Non Current Liabilities Total	-0.24	-0.21	0.92	0.51	0.64	-0.48	0.34	0.11	-0.21	-0.2	-0.03		0.7	-0.22	-0.04	-0.18	0.92	0.53	0.34	0.43	-0.42	0.77	-0.2	-0.16	-0.12	-0.23
Total Liab	0.29	0.41	0.81	0.82	0.99	0.09	-0.22	-0.43	0.39	0.42	0.47	0.7		0.4	0.42	0.35	0.8	0.75	0.55	0.64	0.14	0.47	0.39	0.41	0.27	0.37
Total Current Assets	0.91	1.0	-0.11	0.55	0.51	0.95	-0.95	-0.94	0.99	0.99	0.91	-0.22	0.4		0.78	0.93	-0.19	0.16	0.66	0.49	0.91	-0.33	0.99	0.99	0.75	0.91
Common Stock	0.88	0.8	0.15	0.69	0.51	0.71	-0.68	-0.91	0.79	0.72	0.93	-0.04	0.42	0.78		0.92	0.05	-0.1	0.74	0.43	0.84	-0.26	0.83	0.83	0.73	0.87
Other Stockholder Equity	0.98	0.94	-0.06	0.66	0.45	0.9	-0.86	-0.98	0.93	0.88	0.96	-0.18	0.35	0.93	0.92		-0.16	-0.06	0.69	0.5	0.95	-0.35	0.96	0.96	0.81	0.95
Short Term Debt	-0.22	-0.18	0.99	0.57	0.72	-0.48	0.35	0.09	-0.17	-0.18	0.01	0.92	0.8	-0.19	0.05	-0.16		0.59	0.24	0.37	-0.38	0.73	-0.17	-0.16	-0.09	-0.15
Current Deferred Revenue	-0.06	0.15	0.55	0.39	0.71	-0.1	-0.02	0.0	0.1	0.23	-0.01	0.53	0.75	0.16	-0.1	-0.06	0.59		0.16	0.23	-0.13	0.43	0.08	0.09	-0.21	-0.06
Accounts Payable	0.59	0.67	0.35	0.57	0.67	0.54	-0.63	-0.75	0.66	0.66	0.79	0.34	0.55	0.66	0.74	0.69	0.24	0.16		0.59	0.55	0.04	0.7	0.73	0.6	0.66
Other Liab	0.41	0.51	0.42	0.66	0.66	0.33	-0.42	-0.54	0.51	0.48	0.57	0.43	0.64	0.49	0.43	0.5	0.37	0.23	0.59		0.22	0.46	0.5	0.51	0.48	0.5
Net Tangible Assets	0.95	0.91	-0.3	0.45	0.26	0.94	-0.88	-0.92	0.9	0.86	0.86	-0.42	0.14	0.91	0.84	0.95	-0.38	-0.13	0.55	0.22		-0.57	0.93	0.92	0.75	0.9
Intangible Assets	-0.44	-0.32	0.72	0.23	0.38	-0.53	0.4	0.31	-0.3	-0.29	-0.2	0.77	0.47	-0.33	-0.26	-0.35	0.73	0.43	0.04	0.46	-0.57		-0.32	-0.31	-0.22	-0.39
Net Invested Capital	0.92	0.99	-0.07	0.57	0.5	0.94	-0.96	-0.96	0.99	0.97	0.95	-0.2	0.39	0.99	0.83	0.96	-0.17	0.08	0.7	0.5	0.93	-0.32		1.0	0.82	0.94
Net Working Capital	0.91	0.99	-0.06	0.58	0.51	0.94	-0.96	-0.97	0.99	0.97	0.95	-0.16	0.41	0.99	0.83	0.96	-0.16	0.09	0.73	0.51	0.92	-0.31	1.0		0.82	0.93
Capital Stock	0.72	0.76	0.01	0.49	0.34	0.74	-0.8	-0.83	0.84	0.74	0.87	-0.12	0.27	0.75	0.73	0.81	-0.09	-0.21	0.6	0.48	0.75	-0.22	0.82	0.82		0.86
Property Plant And Equipment Net	0.91	0.92	-0.08	0.59	0.47	0.88	-0.87	-0.96	0.92	0.87	0.93	-0.23	0.37	0.91	0.87	0.95	-0.15	-0.06	0.66	0.5	0.9	-0.39	0.94	0.93	0.86

Click cells to compare fundamentals

Neuroone Medical Account Relationship Matchups

Neuroone Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	5.4M	10.7M	16.0M	18.1M	20.8M	21.9M
Total Assets	4.8M	7.9M	12.8M	8.1M	9.3M	9.8M
Other Current Liab	454.9K	531.5K	632.5K	978.4K	1.1M	1.2M
Total Current Liabilities	2.4M	1.2M	3.1M	1.8M	2.1M	1.2M
Total Stockholder Equity	2.1M	6.6M	9.6M	6.2M	7.2M	7.5M
Net Debt	(2.7M)	(6.6M)	(8.0M)	(5.1M)	(4.6M)	(4.4M)
Retained Earnings	(30.9M)	(40.8M)	(50.8M)	(62.7M)	(56.4M)	(53.6M)
Cash	4.0M	6.9M	8.2M	5.3M	6.1M	6.4M
Cash And Short Term Investments	4.0M	6.9M	11.1M	5.3M	6.1M	6.4M
Liabilities And Stockholders Equity	4.8M	7.9M	12.8M	8.1M	9.3M	9.8M
Non Current Liabilities Total	337.7K	202.9K	119.6K	55.3K	63.6K	60.4K
Total Liab	2.7M	1.4M	3.2M	1.8M	2.1M	1.4M
Total Current Assets	4.2M	7.3M	12.2M	7.3M	8.4M	8.8M
Common Stock	22.2K	12.0K	16.2K	23.9K	27.5K	28.9K
Other Stockholder Equity	32.9M	47.4M	60.4M	68.9M	79.2M	83.2M
Accounts Payable	762.5K	528.8K	927.7K	685.1K	787.9K	475.4K
Net Tangible Assets	(1.4M)	1.9M	6.4M	9.5M	10.9M	11.5M
Non Current Assets Total	604.8K	646.5K	646.8K	784.4K	902.0K	947.2K
Non Currrent Assets Other	200.1K	230.9K	156.5K	(784.4K)	(706.0K)	(670.7K)
Other Current Assets	118.6K	244.0K	296.6K	263.7K	303.3K	318.5K
Intangible Assets	156.5K	134.2K	111.9K	89.6K	80.6K	120.0K
Property Plant Equipment	52.0K	448.2K	512.3K	535.0K	615.2K	646.0K
Net Invested Capital	3.1M	6.6M	9.6M	6.2M	7.2M	7.5M
Net Working Capital	1.8M	6.1M	9.1M	5.5M	6.3M	6.7M
Capital Stock	22.2K	35.8K	16.2K	23.9K	27.5K	22.2K
Property Plant And Equipment Net	448.2K	512.3K	535.0K	694.8K	799.0K	493.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:

How To Invest In Neuroone

Details

Is Neuroone Stock a good investment?

Details

What is Neuroone Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.48)

Revenue Per Share

0.158

Quarterly Revenue Growth

0.311

Return On Assets

(1.43)

Return On Equity

(3.49)

The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neuroone Total Liab vs Net Invested Capital Analysis

Total Liab vs Net Invested Capital

Total Liab vs Net Invested Capital Correlation Analysis

Correlation Coefficient

Total Liab

Net Invested Capital

Neuroone Medical fundamental ratios Correlations

Neuroone Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neuroone Medical fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Net Invested Capital
Cash	+ 0.99	Total Assets
Net Invested Capital	+ 0.99	Total Assets
Net Working Capital	+ 0.99	Total Assets
Short Term Debt	+ 0.99	Short Long Term Debt Total

Other Stockholder Equity	- 0.98	Retained Earnings
Net Working Capital	- 0.97	Retained Earnings
Cash	- 0.97	Net Debt
Net Debt	- 0.97	Total Stockholder Equity
Property Plant And Equipment Net	- 0.96	Retained Earnings
Net Invested Capital	- 0.96	Retained Earnings